Barclays Maintains Overweight on Allegro Microsystems, Lowers Price Target to $31

Barclays analyst Blayne Curtis maintains Allegro Microsystems (NASDAQ:ALGM) with a Overweight and lowers the price target from $35 to $31.

byBenzinga Newsdesk

April 25, 2022

1 minute read

Barclays analyst Blayne Curtis maintains Allegro Microsystems (NASDAQ:ALGM) with a Overweight and lowers the price target from $35 to $31.

Why These Casino Stocks Are Moving Lower, Here’s 45 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 8:48 AM

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

ADTX

Biotech Acquisition Company and Blade Therapeutics Announced Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination from June 1 to June 3

By Charles Gross

Today, 8:48 AM

Biotech Acquisition Company (NASDAQ: BIOT) ("BAC"), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc.

BIOT

Kratos Secures $20M International Drone Contract

By Akanksha Bakshi

Today, 8:48 AM

Kratos Defense & Security Solutions, Inc’s (NASDAQ:KTOS) Kratos Unmanned Systems Division received a $20 million contract award from an international customer…

KTOS